ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

Community Based Organizing Nearly Complete; Conn. Still Planning

November 25, 1977

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003

CAP, ASCCP Recommendations Standardize Lesion Terminology

July 27, 2012

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021

Clearinghouse Asks Short Term Test Use To Help In Chemical Selection

September 17, 1977